Further investigation of the role of the heparanase–shed syndecan-1 axis in breast cancer progression should focus on disruption of heparanase function, which is likely to profoundly affect tumor growth, metastasis, and osteolysis. This evidence concerns the gene HPSE and breast carcinoma.